Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 30 Sept 2026 for ANI Pharmaceuticals INC, €183k. Read the official filing
Filing timeline
BuySaleStephen P. Carey
Insider track record
Disclosed buys
0
Disclosed sells
9
Signal history
Stephen P. Carey: trading record in brief
Stephen P. Carey, listed as finance chief, appears in our data through filings on ANI Pharmaceuticals Inc shares, published by SEC (Form 4). Between 23 March 2022 and 29 September 2026, the trades on record add up to 40 filings.
No open-market purchase appears, only 9 sales worth €2.7M. The amount is not disclosed for 1 filing. Besides market trades, the filings include 27 share grants and 4 option exercises. 2026 to date brings no purchases and 6 sales.
The latest filing, published on 30 September 2026, reports an open-market sale of €183k in ANI Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stephen P. Carey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
2,850 shares@ US$73.00Common StockSEC:0001674236-26-000024:0
2,850 shares@ US$72.800.012% mcap1.8% of flowCommon StockSEC:0001674236-26-000022:0
2,850 shares@ US$81.360.014% mcap2.0% of flowCommon StockSEC:0001674236-26-000019:0
3,313 shares@ US$49.510.0096% mcap1.4% of flowCommon StockSEC:0001674236-26-000017:0
3,313 shares@ US$86.000.017% mcap2.5% of flowCommon StockSEC:0001674236-26-000017:1
2,850 sharesCommon StockSEC:0001674236-26-000015:0
3,312 shares@ US$49.510.0075% mcap1.4% of flowCommon StockSEC:0001674236-26-000013:0
3,312 shares@ US$80.000.012% mcap2.3% of flowCommon StockSEC:0001674236-26-000013:1
5,150 shares@ US$74.040.019% mcap3.2% of flowCommon StockSEC:0001674236-26-000010:0
3,312 shares@ US$49.511.4% of flowCommon StockSEC:0001674236-26-000008:0
22,233 shares@ US$77.1514.4% of flowCommon StockSEC:0001674236-26-000006:0
2,448 shares@ US$77.361.6% of flowCommon StockSEC:0001674236-26-000004:1
2,829 shares@ US$76.701.8% of flowCommon StockSEC:0001674236-26-000004:0
5,503 shares@ US$76.253.5% of flowCommon StockSEC:0001674236-26-000002:0
50,000 shares@ US$46.4919.7% of flowCommon StockSEC:0001674236-25-000010:0
6,210 shares@ US$64.263.6% of flowCommon StockSEC:0001674236-25-000008:0
5,150 shares@ US$60.622.9% of flowCommon StockSEC:0001674236-25-000006:0
1,861 shares@ US$61.891.1% of flowCommon StockSEC:0001674236-25-000004:0
1,730 shares@ US$58.921.0% of flowCommon StockSEC:0001674236-25-000002:2
24,808 shares0Common StockSEC:0001674236-25-000002:0
16,538 shares0Common StockSEC:0001674236-25-000002:1
7,500 shares@ US$55.793.9% of flowCommon StockSEC:0001674236-24-000015:0
5,000 shares@ US$63.582.9% of flowCommon StockSEC:0001674236-24-000013:0
4,534 shares@ US$66.962.8% of flowCommon StockSEC:0001674236-24-000011:0
6,210 shares@ US$69.583.9% of flowCommon StockSEC:0001674236-24-000009:0
25 of 40 declarations
